Minimally invasive device and bioabsorbable hemostatic powder for managing noncompressible torso hemorrhage

Ended Project Grant Awarded Last action

Award ID
W81XWH2110969
Recipient
Awarding agency
Obligated
$2,000,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Milwaukee, WI 53233, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment This modification:1.extends the POP by 12 months. Technical and financial reporting shall continue in accordance with the award terms and conditions.2.updates… $0
Amendment $0
Original award $2,000,000

Subawards

Subrecipient Amount Awarded
Comotion Drug Delivery Systems Inc. Major Task 4.2 – Generate materials to supply studies in Objectives 1-3.Subtask 4.2.2: Manufacture and characterize a batch of the refined CounterFlow-AP… $30,000
Comotion Drug Delivery Systems Inc. CoMotion Drug Delivery Systems will participate in this project by manufacturing and characterizing a batch of the refined CounterFlow-AP formulation and… $560,000
University Of Washington University of Washington will participate in this project by measuring the safety and effectiveness of CounterFlow-AP containing various doses of thrombin and… $747,058

Quick answers

Who received award W81XWH2110969?

W81XWH2110969 was awarded to Versiti Blood Health, Inc. by Defense Health Agency (Department of Defense) on September 30, 2021.

How much is award W81XWH2110969 worth?

$2,000,000 has been obligated on W81XWH2110969.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login